PMID- 26215493
OWN - NLM
STAT- MEDLINE
DCOM- 20160601
LR  - 20190221
IS  - 1879-291X (Electronic)
IS  - 0301-5629 (Linking)
VI  - 41
IP  - 10
DP  - 2015 Oct
TI  - Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine 
      Ablation in Patients with Papillary Thyroid Carcinoma.
PG  - 2640-5
LID - S0301-5629(15)00408-1 [pii]
LID - 10.1016/j.ultrasmedbio.2015.06.010 [doi]
AB  - The aim of this study was to evaluate the ultrasonographic features of the major 
      salivary glands (MSGs) after post-operative radioactive iodine ablation (RIA) in 
      patients with papillary thyroid carcinoma (PTC). The study population comprised 
      202 consecutively registered PTC patients who had undergone total thyroidectomy, 
      RIA and follow-up neck ultrasonography. The ultrasonographic features of the MSGs 
      in each patient were retrospectively evaluated by a single radiologist, and the 
      presence of post-RIA changes was determined by direct comparisons of pre- and 
      post-RIA follow-up ultrasonographic scans. Of the 202 patients, 94 (46.5%) had 
      post-RIA changes in the MSGs on follow-up ultrasonography. RIA dose was closely 
      associated with the prevalence of post-RIA changes. Post-RIA changes were more 
      common in the parotid glands (n = 93, 46.0%) than in the submandibular glands (n 
      = 7, 3.5%). Common ultrasonographic findings representing post-RIA changes in 
      MSGs included coarse echotexture, decreased echogenicity, lobulated margin and 
      decreased gland size.
CI  - Copyright (c) 2015 World Federation for Ultrasound in Medicine & Biology. Published 
      by Elsevier Inc. All rights reserved.
FAU - Kim, Dong Wook
AU  - Kim DW
AD  - Department of Radiology, Busan Paik Hospital, Inje University College of 
      Medicine, Busan, South Korea. Electronic address: dwultra@lycos.co.kr.
LA  - eng
PT  - Controlled Clinical Trial
PT  - Journal Article
DEP - 20150726
PL  - England
TA  - Ultrasound Med Biol
JT  - Ultrasound in medicine & biology
JID - 0410553
RN  - 0 (Iodine Radioisotopes)
RN  - 0 (Radiopharmaceuticals)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma/diagnostic imaging/*radiotherapy
MH  - Carcinoma, Papillary
MH  - Female
MH  - Humans
MH  - Iodine Radioisotopes/*adverse effects/therapeutic use
MH  - Male
MH  - Middle Aged
MH  - Radiation Injuries/*diagnostic imaging/*etiology
MH  - Radiopharmaceuticals/adverse effects/therapeutic use
MH  - Reproducibility of Results
MH  - Salivary Gland Diseases/*diagnostic imaging/*etiology
MH  - Sensitivity and Specificity
MH  - Thyroid Cancer, Papillary
MH  - Thyroid Neoplasms/diagnostic imaging/*radiotherapy
MH  - Treatment Outcome
MH  - Ultrasonography/methods
OTO - NOTNLM
OT  - Computed tomography
OT  - Major salivary glands
OT  - Papillary thyroid carcinoma
OT  - Radioactive iodine ablation
OT  - Ultrasonography
EDAT- 2015/07/29 06:00
MHDA- 2016/06/02 06:00
CRDT- 2015/07/29 06:00
PHST- 2015/04/13 00:00 [received]
PHST- 2015/06/08 00:00 [revised]
PHST- 2015/06/14 00:00 [accepted]
PHST- 2015/07/29 06:00 [entrez]
PHST- 2015/07/29 06:00 [pubmed]
PHST- 2016/06/02 06:00 [medline]
AID - S0301-5629(15)00408-1 [pii]
AID - 10.1016/j.ultrasmedbio.2015.06.010 [doi]
PST - ppublish
SO  - Ultrasound Med Biol. 2015 Oct;41(10):2640-5. doi: 
      10.1016/j.ultrasmedbio.2015.06.010. Epub 2015 Jul 26.